• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左心房大小与非瓣膜性心房颤动急性缺血性脑卒中后复发性脑卒中的长期风险。

Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.

机构信息

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Department of Neurology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

出版信息

J Am Heart Assoc. 2017 Aug 15;6(8):e006402. doi: 10.1161/JAHA.117.006402.

DOI:10.1161/JAHA.117.006402
PMID:28862939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5586470/
Abstract

BACKGROUND

Among patients with ischemic stroke and atrial fibrillation, which ones are at high risk of recurrent stroke is unclear. This study aimed to determine whether left atrial size was associated with long-term risk of stroke recurrence in patients with nonvalvular atrial fibrillation.

METHODS AND RESULTS

In this multicenter prospective cohort study, nonvalvular atrial fibrillation patients hospitalized for acute ischemic stroke were enrolled and followed up after discharge. Indexed-left atrial diameter was obtained by dividing left atrial diameter by body surface area. Cause-specific and subdistribution hazard ratios of recurrent stroke were estimated by Cox proportional hazards and Fine-Gray models, respectively. Risk prediction was evaluated by integrated discrimination improvement and net reclassification improvement. In total, 1611 patients (77.8±10.2 [mean±SD] years, 44.5% female) were included. During follow-up for 2.40±1.63 (mean±SD) years, 251 patients had recurrent stroke and 514 patients died. An increased indexed-left atrial diameter (per 1 cm/m) was significantly associated with elevated risk of stroke recurrence (hazard ratio 1.60, 95% CI 1.30-1.98). The association was maintained when death was regarded as the competing risk and in 1464 patients who were treated with anticoagulants (hazard ratio 1.59, 95% CI 1.27-2.00). Risk prediction for recurrent stroke was significantly improved by adding indexed-left atrial diameter to the baseline model composed of the factors in the CHADS score or those in the CHADS-VASc score.

CONCLUSION

These findings suggest that left atrial enlargement is associated with an increased risk of recurrent stroke in nonvalvular atrial fibrillation patients with ischemic stroke.

摘要

背景

在患有缺血性卒中和心房颤动的患者中,哪些患者发生复发性卒中的风险较高尚不清楚。本研究旨在确定左心房大小与非瓣膜性心房颤动患者的长期卒中复发风险是否相关。

方法和结果

在这项多中心前瞻性队列研究中,招募了因急性缺血性卒中住院的非瓣膜性心房颤动患者,并在出院后进行随访。通过将左心房直径除以体表面积来获得左心房指数直径。通过 Cox 比例风险和 Fine-Gray 模型分别估计复发性卒中的病因特异性和亚分布风险比。通过综合判别改善和净重新分类改善来评估风险预测。共纳入 1611 例患者(77.8±10.2[均数±标准差]岁,44.5%为女性)。在 2.40±1.63(均数±标准差)年的随访期间,251 例患者发生复发性卒中,514 例患者死亡。左心房指数直径(每 1cm/m)增加与卒中复发风险升高显著相关(风险比 1.60,95%CI 1.30-1.98)。当将死亡视为竞争风险时,以及在 1464 例接受抗凝治疗的患者中,这种相关性仍然存在(风险比 1.59,95%CI 1.27-2.00)。通过将左心房指数直径添加到由 CHADS 评分或 CHADS-VASc 评分中的因素组成的基线模型中,可显著改善复发性卒中的风险预测。

结论

这些发现表明,左心房扩大与缺血性卒中伴非瓣膜性心房颤动患者的复发性卒中风险增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a6/5586470/509da480e7e9/JAH3-6-e006402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a6/5586470/509da480e7e9/JAH3-6-e006402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a6/5586470/509da480e7e9/JAH3-6-e006402-g001.jpg

相似文献

1
Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.左心房大小与非瓣膜性心房颤动急性缺血性脑卒中后复发性脑卒中的长期风险。
J Am Heart Assoc. 2017 Aug 15;6(8):e006402. doi: 10.1161/JAHA.117.006402.
2
The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.老年慢性肾脏病合并心房颤动患者抗凝、缺血性卒中和出血的相关性。
Kidney Int. 2017 Apr;91(4):928-936. doi: 10.1016/j.kint.2016.10.017. Epub 2016 Dec 22.
3
Prognostic value of low left atrial appendage wall velocity in patients with ischemic stroke and atrial fibrillation.左心耳壁运动速度低对缺血性脑卒中合并心房颤动患者预后的预测价值。
J Am Soc Echocardiogr. 2012 May;25(5):576-83. doi: 10.1016/j.echo.2012.01.012. Epub 2012 Feb 10.
4
Detection of atrial fibrillation after stroke and the risk of recurrent stroke.卒中后心房颤动的检测与复发卒中的风险。
J Stroke Cerebrovasc Dis. 2012 Nov;21(8):726-31. doi: 10.1016/j.jstrokecerebrovasdis.2011.03.008. Epub 2011 May 5.
5
CHADS-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study.用于识别真正低风险房颤卒中的CHADS-VASc评分:一项韩国全国性队列研究
Stroke. 2017 Nov;48(11):2984-2990. doi: 10.1161/STROKEAHA.117.018551. Epub 2017 Sep 22.
6
Excessive Premature Atrial Complexes and the Risk of Recurrent Stroke or Death in an Ischemic Stroke Population.缺血性卒中人群中过早搏动过多与复发性卒中或死亡风险
J Stroke Cerebrovasc Dis. 2017 Jun;26(6):1163-1170. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.038. Epub 2016 Nov 25.
7
Early Initiation of Direct Oral Anticoagulants After Onset of Stroke and Short- and Long-Term Outcomes of Patients With Nonvalvular Atrial Fibrillation.卒中后直接口服抗凝剂的早期启动与非瓣膜性心房颤动患者的短期和长期结局。
Stroke. 2020 Mar;51(3):883-891. doi: 10.1161/STROKEAHA.119.028118. Epub 2020 Jan 22.
8
Correlation between left atrial spontaneous echocardiographic contrast and 5-year stroke/death in patients with non-valvular atrial fibrillation.左心房自发性超声对比与非瓣膜性心房颤动患者 5 年卒中和死亡的相关性。
Arch Cardiovasc Dis. 2020 Aug-Sep;113(8-9):525-533. doi: 10.1016/j.acvd.2020.02.003. Epub 2020 Aug 29.
9
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.CHA2DS2-VASc 评分在 CHADS2 评分为 0-1 的房颤患者中对卒中风险分层的价值:一项全国性队列研究。
Thromb Haemost. 2012 Jun;107(6):1172-9. doi: 10.1160/TH12-03-0175. Epub 2012 Apr 3.
10
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.在接受抗凝治疗的房颤患者中,HAS-BLED 评分对大出血的预测准确性优于 CHADS2 或 CHA2DS2-VASc 评分。
J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.

引用本文的文献

1
2025 THRS Expert Consensus of Imaging Assessment in Atrial Fibrillation. .2025年心房颤动影像评估的经导管射频消融术专家共识
Acta Cardiol Sin. 2025 Jul;41(4):446-477. doi: 10.6515/ACS.202507_41(4).20250526A.
2
Ischemic Stroke in Patients Under Oral Anticoagulation: The Achilles Heel of Atrial Fibrillation Management.接受口服抗凝治疗患者的缺血性卒中:心房颤动管理的致命弱点
Brain Sci. 2025 Apr 26;15(5):454. doi: 10.3390/brainsci15050454.
3
Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.基于新型生物标志物的房颤卒中风险评分的性能和验证。
Circulation. 2016 Nov 29;134(22):1697-1707. doi: 10.1161/CIRCULATIONAHA.116.022802. Epub 2016 Aug 28.
2
Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.非瓣膜性心房颤动患者缺血性卒中的病因
Cerebrovasc Dis. 2016;42(3-4):196-204. doi: 10.1159/000445723. Epub 2016 Apr 26.
3
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
心房颤动患者抗凝治疗后复发性卒中的残余风险:一项系统评价和荟萃分析。
JAMA Neurol. 2025 May 21. doi: 10.1001/jamaneurol.2025.1337.
4
Combined Catheter Ablation and Left Atrial Appendage Occlusion in Atrial Fibrillation: From Data to Clinical Reality.房颤的导管消融与左心耳封堵联合应用:从数据到临床实践
Cardiovasc Drugs Ther. 2025 Apr 16. doi: 10.1007/s10557-025-07685-2.
5
The usefulness of global longitudinal peak strain and left atrial volume index in predicting atrial fibrillation in patients with ischemic stroke.整体纵向峰值应变和左心房容积指数在预测缺血性脑卒中患者房颤方面的效用。
Front Neurol. 2024 Jan 5;14:1287609. doi: 10.3389/fneur.2023.1287609. eCollection 2023.
6
Left atrial enlargement and high uric acid level are risk factors for left atrial thrombus or dense spontaneous echo contrast in atrial fibrillation patients with low to moderate embolic risk assessed by CHADS-VAS score.通过CHADS-VAS评分评估为低至中度栓塞风险的房颤患者中,左心房扩大和高尿酸水平是左心房血栓或密集自发显影对比的危险因素。
Front Cardiovasc Med. 2023 Jul 3;10:937770. doi: 10.3389/fcvm.2023.937770. eCollection 2023.
7
The contribution of competing mechanisms in stroke despite anticoagulation in patients with atrial fibrillation.尽管在房颤患者中进行抗凝治疗,但竞争机制仍会导致卒中。
Eur Stroke J. 2023 Jun;8(2):541-548. doi: 10.1177/23969873231168367. Epub 2023 Apr 3.
8
The effect of different preoperative left atrial appendage emptying speeds on left atrial function in patients with persistent atrial fibrillation after left atrial appendage closure combined with catheter ablation.经皮左心耳封堵联合导管消融术治疗持续性心房颤动患者不同左心耳排空速度对左心耳功能的影响。
BMC Cardiovasc Disord. 2022 Sep 6;22(1):399. doi: 10.1186/s12872-022-02842-z.
9
The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.心房颤动中的心房——关于如何处理心房纤维化基质的临床综述
Front Cardiovasc Med. 2022 Jul 4;9:879984. doi: 10.3389/fcvm.2022.879984. eCollection 2022.
10
The Relationship Between Mitral Annular Calcification and Controlling Nutritional Status Score.二尖瓣环钙化与控制营养状况评分的关系。
Braz J Cardiovasc Surg. 2022 Dec 1;37(6):908-913. doi: 10.21470/1678-9741-2020-0443.
新型基于生物标志物的 ABC(年龄、生物标志物、临床病史)-房颤患者出血风险评分:一项推导和验证研究。
Lancet. 2016 Jun 4;387(10035):2302-2311. doi: 10.1016/S0140-6736(16)00741-8. Epub 2016 Apr 4.
4
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.ABC(年龄、生物标志物、临床病史)卒中风险评分:一种基于生物标志物的房颤卒中预测风险评分。
Eur Heart J. 2016 May 21;37(20):1582-90. doi: 10.1093/eurheartj/ehw054. Epub 2016 Feb 25.
5
Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database.ATRIA、CHADS2 和 CHA2DS2-VASc 风险评分在预测心房颤动患者中风中的比较表现:来自全国初级保健数据库的结果。
J Am Coll Cardiol. 2015 Oct 27;66(17):1851-9. doi: 10.1016/j.jacc.2015.08.033.
6
Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study.左心房扩大与卒中复发:北曼哈顿卒中研究
Stroke. 2015 Jun;46(6):1488-93. doi: 10.1161/STROKEAHA.115.008711. Epub 2015 Apr 23.
7
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.超声心动图成人左心室容量和射血分数测量:美国超声心动图学会和欧洲心血管影像协会的更新建议。
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14. doi: 10.1016/j.echo.2014.10.003.
8
Report of the committee on the classification and diagnostic criteria of diabetes mellitus.糖尿病分类和诊断标准委员会报告。
J Diabetes Investig. 2010 Oct 19;1(5):212-28. doi: 10.1111/j.2040-1124.2010.00074.x.
9
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.高敏肌钙蛋白 I 用于评估房颤患者的风险:来自阿哌沙班用于心房颤动减少卒中和其他血栓栓塞事件(ARISTOTLE)试验的见解。
Circulation. 2014 Feb 11;129(6):625-34. doi: 10.1161/CIRCULATIONAHA.113.006286. Epub 2013 Nov 13.
10
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.高敏肌钙蛋白 T 与阿哌沙班或华法林治疗期间心房颤动患者的危险分层。
J Am Coll Cardiol. 2014;63(1):52-61. doi: 10.1016/j.jacc.2013.07.093. Epub 2013 Sep 19.